Chungcheongbuk-do, South Korea

Dong Kyu Lee

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medytox Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Kyu Lee. Retrieved from https://idiyas.com/inventor/dong-kyu-lee-e3hh3uwu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dong Kyu Lee

Introduction

Dong Kyu Lee is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polynucleotides.

Latest Patents

Dong Kyu Lee holds a patent for a recombinant polynucleotide coding for a polypeptide that includes a reporter moiety, a substrate moiety, and a destabilizing moiety. This invention provides a method to measure the level of a protease using the recombinant polynucleotide, showcasing his innovative approach to biotechnological applications.

Career Highlights

He is currently associated with Medytox Inc., a company known for its advancements in biopharmaceuticals. His work at Medytox Inc. reflects his commitment to enhancing medical technologies and therapeutic solutions.

Collaborations

Some of his notable coworkers include Hyun Ho Jung and Gi Hyeok Yang, who contribute to the collaborative environment at Medytox Inc. Their combined expertise fosters innovation and progress in their respective fields.

Conclusion

Dong Kyu Lee's contributions to biotechnology through his patent and work at Medytox Inc. highlight his role as an influential inventor in the industry. His innovative spirit continues to drive advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…